Immune cell responses in pancreatic cancer and their clinical application

Pancreatic cancer is one of the most lethal diseases around the world, for hardly detection and poor prognosis. Recent years, functions of the tumor microenvironment and immune cells attract people’s view and there is emerging evidence implicating some immune cells hold the key points in the metabol...

Full description

Bibliographic Details
Main Authors: Xulin Zhou, Yongmin Yan, Min Xu
Format: Article
Language:English
Published: SAGE Publishing 2022-01-01
Series:European Journal of Inflammation
Online Access:https://doi.org/10.1177/20587392211044381
_version_ 1828822710531129344
author Xulin Zhou
Yongmin Yan
Min Xu
author_facet Xulin Zhou
Yongmin Yan
Min Xu
author_sort Xulin Zhou
collection DOAJ
description Pancreatic cancer is one of the most lethal diseases around the world, for hardly detection and poor prognosis. Recent years, functions of the tumor microenvironment and immune cells attract people’s view and there is emerging evidence implicating some immune cells hold the key points in the metabolism, invasion, and metastasis in pancreatic cancer. In this review, we highlight some main immune cells, such as Tumor-associated neutrophils (TANs) and macrophages (TAMs), Pancreatic stellate cells (PSCs), Myeloid-derived suppressor cells (MDSCs), and Regulatory T cells (Tregs). Furthermore, we review current clinical applications and discuss potential values in future.
first_indexed 2024-12-12T13:18:59Z
format Article
id doaj.art-118d9783e4d24239848c7e5a00578977
institution Directory Open Access Journal
issn 2058-7392
language English
last_indexed 2024-12-12T13:18:59Z
publishDate 2022-01-01
publisher SAGE Publishing
record_format Article
series European Journal of Inflammation
spelling doaj.art-118d9783e4d24239848c7e5a005789772022-12-22T00:23:20ZengSAGE PublishingEuropean Journal of Inflammation2058-73922022-01-012010.1177/20587392211044381Immune cell responses in pancreatic cancer and their clinical applicationXulin ZhouYongmin YanMin XuPancreatic cancer is one of the most lethal diseases around the world, for hardly detection and poor prognosis. Recent years, functions of the tumor microenvironment and immune cells attract people’s view and there is emerging evidence implicating some immune cells hold the key points in the metabolism, invasion, and metastasis in pancreatic cancer. In this review, we highlight some main immune cells, such as Tumor-associated neutrophils (TANs) and macrophages (TAMs), Pancreatic stellate cells (PSCs), Myeloid-derived suppressor cells (MDSCs), and Regulatory T cells (Tregs). Furthermore, we review current clinical applications and discuss potential values in future.https://doi.org/10.1177/20587392211044381
spellingShingle Xulin Zhou
Yongmin Yan
Min Xu
Immune cell responses in pancreatic cancer and their clinical application
European Journal of Inflammation
title Immune cell responses in pancreatic cancer and their clinical application
title_full Immune cell responses in pancreatic cancer and their clinical application
title_fullStr Immune cell responses in pancreatic cancer and their clinical application
title_full_unstemmed Immune cell responses in pancreatic cancer and their clinical application
title_short Immune cell responses in pancreatic cancer and their clinical application
title_sort immune cell responses in pancreatic cancer and their clinical application
url https://doi.org/10.1177/20587392211044381
work_keys_str_mv AT xulinzhou immunecellresponsesinpancreaticcancerandtheirclinicalapplication
AT yongminyan immunecellresponsesinpancreaticcancerandtheirclinicalapplication
AT minxu immunecellresponsesinpancreaticcancerandtheirclinicalapplication